Warning letters, 483s, Recalls, Import Alerts, Audit observations
Sun Pharma’s Dadra Unit was issued FDA Warning letter in June 2024, following critical observations
Laurus Synthesis was issued an Untitled Letter by USFDA in May 2024, following critical observations
Sun Pharma Dadra unit (FEI 3004561553) was inspected by USFDA in December 2023 by FDA
USFDA inspection of Cipla, Patalganga site manufacturing APIs and Tablets resulted in USFDA 483 with
USFDA 483 to Lupin Pithampur in Mar 2023 (Inspectors Eileen A Liu, Yvins Dezan) cites
Warning letter / Centrient India / MARCS-CMS 640196/ 320-23-06/ DECEMBER 07, 2022/ Observation 3 The
